• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epigenetic reprogramming during prostate cancer progression: A perspective from development.前列腺癌进展过程中的表观遗传重编程:从发育角度看。
Semin Cancer Biol. 2022 Aug;83:136-151. doi: 10.1016/j.semcancer.2021.01.009. Epub 2021 Feb 2.
2
Rewriting cellular fate: epigenetic interventions in obesity and cellular programming.改写细胞命运:肥胖症和细胞编程中的表观遗传干预。
Mol Med. 2024 Oct 10;30(1):169. doi: 10.1186/s10020-024-00944-2.
3
The epigenetic and transcriptional landscape of neuroendocrine prostate cancer.神经内分泌前列腺癌的表观遗传学和转录组学特征。
Endocr Relat Cancer. 2020 Feb;27(2):R35-R50. doi: 10.1530/ERC-19-0420.
4
Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies.拉平沃丁顿:直接编程的出现与细胞命运层级的丧失。
Nat Rev Mol Cell Biol. 2013 Apr;14(4):225-36. doi: 10.1038/nrm3543. Epub 2013 Mar 13.
5
Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling.细胞命运重编程的表观遗传学及其对神经疾病建模的影响。
Neurobiol Dis. 2017 Mar;99:84-120. doi: 10.1016/j.nbd.2016.11.007. Epub 2016 Nov 23.
6
A deterministic map of Waddington's epigenetic landscape for cell fate specification.用于细胞命运决定的沃丁顿表观遗传景观的确定性图谱。
BMC Syst Biol. 2011 May 27;5:85. doi: 10.1186/1752-0509-5-85.
7
Induced pluripotent stem cell technology for dissecting the cancer epigenome.用于剖析癌症表观基因组的诱导多能干细胞技术。
Cancer Sci. 2015 Oct;106(10):1251-6. doi: 10.1111/cas.12758. Epub 2015 Sep 25.
8
The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.表观遗传学在前列腺癌和良性前列腺增生的发生、诊断及治疗中的作用不断扩展。
J Urol. 2007 Mar;177(3):822-31. doi: 10.1016/j.juro.2006.10.063.
9
The reversibility of cellular determination: An evolutive pattern of epigenetic plasticity.细胞决定的可逆性:一种表观遗传可塑性的进化模式。
Biosystems. 2022 Nov;221:104774. doi: 10.1016/j.biosystems.2022.104774. Epub 2022 Sep 5.
10
Epigenetics, Enhancer Function and 3D Chromatin Organization in Reprogramming to Pluripotency.表观遗传学、增强子功能和重编程为多能性的 3D 染色质组织。
Cells. 2022 Apr 21;11(9):1404. doi: 10.3390/cells11091404.

引用本文的文献

1
Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung Cancer.PD-L1高表达非小细胞肺癌中的免疫治疗耐药性及治疗策略
Onco Targets Ther. 2025 Aug 29;18:953-966. doi: 10.2147/OTT.S539978. eCollection 2025.
2
Cancer-specific Regulation of Metabolic and Epigenetic Pathways by Dietary Phytochemicals.膳食植物化学物质对代谢和表观遗传途径的癌症特异性调控
Pharm Res. 2025 Aug;42(8):1443-1457. doi: 10.1007/s11095-025-03898-0. Epub 2025 Aug 4.
3
CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape.CD248诱导癌症相关成纤维细胞上的PD-L1表达以促进非小细胞肺癌免疫逃逸。
Front Cell Dev Biol. 2025 Jul 15;13:1635915. doi: 10.3389/fcell.2025.1635915. eCollection 2025.
4
Ten-Eleven Translocation Family Proteins: Structure, Biological Functions, Diseases, and Targeted Therapy.10-11易位家族蛋白:结构、生物学功能、疾病及靶向治疗
MedComm (2020). 2025 Jul 1;6(7):e70245. doi: 10.1002/mco2.70245. eCollection 2025 Jul.
5
Identification of a Selective Cell-Active Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) for the Treatment of Prostate Cancer by Structure-Based Virtual Screening.通过基于结构的虚拟筛选鉴定一种用于治疗前列腺癌的蛋白质精氨酸甲基转移酶5(PRMT5)的选择性细胞活性抑制剂。
Chem Biol Drug Des. 2025 Jun;105(6):e70136. doi: 10.1111/cbdd.70136.
6
YEATS2: a novel cancer epigenetic reader and potential therapeutic target.YEATS2:一种新型癌症表观遗传阅读器及潜在治疗靶点。
Cancer Cell Int. 2025 Apr 26;25(1):162. doi: 10.1186/s12935-025-03797-9.
7
From microscopes to molecules: The evolution of prostate cancer diagnostics.从显微镜到分子:前列腺癌诊断的演变
Cytojournal. 2024 Aug 29;21:29. doi: 10.25259/Cytojournal_36_2024. eCollection 2024.
8
Promising therapy for neuroendocrine prostate cancer: current status and future directions.神经内分泌前列腺癌的前景疗法:现状与未来方向
Ther Adv Med Oncol. 2024 Aug 8;16:17588359241269676. doi: 10.1177/17588359241269676. eCollection 2024.
9
RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemia.RAG1 和 RAG2 的非核心区域与 BCR-ABL1 驱动的 B 细胞谱系淋巴母细胞白血病中的白血病发生和非靶点 V(D)J 重组有关。
Elife. 2024 Jul 26;12:RP91030. doi: 10.7554/eLife.91030.
10
Epigenetic-related gene-based prognostic model construction and validation in prostate adenocarcinoma.基于表观遗传相关基因的前列腺腺癌预后模型构建与验证
Heliyon. 2024 May 9;10(10):e30941. doi: 10.1016/j.heliyon.2024.e30941. eCollection 2024 May 30.

本文引用的文献

1
Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression.转录网络涉及 ERG 和 AR 协调远端同源盒-1 介导的前列腺癌进展。
Nat Commun. 2021 Sep 7;12(1):5325. doi: 10.1038/s41467-021-25623-2.
2
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.SWI/SNF 复合物的特异性组成在前列腺癌谱系可塑性中的作用。
Nat Commun. 2020 Nov 3;11(1):5549. doi: 10.1038/s41467-020-19328-1.
3
ACK1-AR and AR-HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers.ACK1-AR和AR-HOXB13信号轴:致死性前列腺癌的表观遗传调控
NAR Cancer. 2020 Sep;2(3):zcaa018. doi: 10.1093/narcan/zcaa018. Epub 2020 Aug 27.
4
miR-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis.微小RNA-137-3p通过调控JNK3/EZH2轴调节前列腺癌进展
Onco Targets Ther. 2020 Aug 10;13:7921-7932. doi: 10.2147/OTT.S256161. eCollection 2020.
5
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.FOXA1 的染色质结合由 LSD1 介导的去甲基化促进,发生在前列腺癌中。
Nat Genet. 2020 Oct;52(10):1011-1017. doi: 10.1038/s41588-020-0681-7. Epub 2020 Aug 31.
6
Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatment.转移性前列腺癌在雄激素靶向治疗期间的无细胞游离 DNA 甲基组动力学。
Epigenomics. 2020 Aug;12(15):1317-1332. doi: 10.2217/epi-2020-0173. Epub 2020 Sep 1.
7
DNA Framework-Supported Electrochemical Analysis of DNA Methylation for Prostate Cancers.DNA 框架支持的前列腺癌 DNA 甲基化电化学分析。
Nano Lett. 2020 Oct 14;20(10):7028-7035. doi: 10.1021/acs.nanolett.0c01898. Epub 2020 Sep 10.
8
The DNA methylation landscape of advanced prostate cancer.晚期前列腺癌的 DNA 甲基化图谱。
Nat Genet. 2020 Aug;52(8):778-789. doi: 10.1038/s41588-020-0648-8. Epub 2020 Jul 13.
9
The Contribution of Epigenetics to Cancer Immunotherapy.表观遗传学在癌症免疫治疗中的贡献。
Trends Immunol. 2020 Aug;41(8):676-691. doi: 10.1016/j.it.2020.06.002. Epub 2020 Jul 2.
10
p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer.p300 介导的组蛋白去甲基酶 JMJD1A 乙酰化可防止其被泛素连接酶 STUB1 降解,并增强其在前列腺癌中的活性。
Cancer Res. 2020 Aug 1;80(15):3074-3087. doi: 10.1158/0008-5472.CAN-20-0233. Epub 2020 Jun 10.

前列腺癌进展过程中的表观遗传重编程:从发育角度看。

Epigenetic reprogramming during prostate cancer progression: A perspective from development.

机构信息

Molecular Oncology Laboratory, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, 208016, U.P., India.

Molecular Oncology Laboratory, Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, 208016, U.P., India; Mehta Family Center for Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur, 208016, India.

出版信息

Semin Cancer Biol. 2022 Aug;83:136-151. doi: 10.1016/j.semcancer.2021.01.009. Epub 2021 Feb 2.

DOI:10.1016/j.semcancer.2021.01.009
PMID:33545340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7612861/
Abstract

Conrad Waddington's theory of epigenetic landscape epitomize the process of cell fate and cellular decision-making during development. Wherein the epigenetic code maintains patterns of gene expression in pluripotent and differentiated cellular states during embryonic development and differentiation. Over the years disruption or reprogramming of the epigenetic landscape has been extensively studied in the course of cancer progression. Cellular dedifferentiation being a key hallmark of cancer allow us to take cues from the biological processes involving epigenetic reprogramming in development such as the cellular differentiation and morphogenesis. Here, we discuss the role of epigenetic landscape and its modifiers in cell-fate determination, differentiation and prostate cancer progression. Lately, the emergence of RNA-modifications has also furthered our understanding of epigenetics in cancer. The overview of the epigenetic code regulating androgen signalling, and progression to aggressive neuroendocrine stage of PCa reinforces its gene regulatory functions during the development of prostate gland as well as cancer progression. Additionally, we also highlight the clinical implications of cancer cell epigenome, and discuss the recent advancements in the therapeutic strategies targeting the advanced stage disease.

摘要

康拉德·沃丁顿(Conrad Waddington)的表观遗传景观理论是胚胎发育过程中细胞命运和细胞决策的过程。在胚胎发育和分化过程中,表观遗传密码维持多能性和分化细胞状态下的基因表达模式。多年来,在癌症进展过程中,对表观遗传景观的破坏或重编程进行了广泛的研究。细胞去分化是癌症的一个关键标志,这使我们能够从涉及发育过程中表观遗传重编程的生物学过程中得到启示,如细胞分化和形态发生。在这里,我们讨论了表观遗传景观及其修饰物在细胞命运决定、分化和前列腺癌进展中的作用。最近,RNA 修饰的出现也进一步加深了我们对癌症中表观遗传学的理解。调节雄激素信号的表观遗传密码概述,以及向前列腺癌侵袭性神经内分泌阶段的进展,加强了其在前列腺发育以及癌症进展过程中的基因调控功能。此外,我们还强调了癌细胞表观基因组的临床意义,并讨论了针对晚期疾病的治疗策略的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f1/7612861/0581e97c2ced/EMS131904-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f1/7612861/283961570e7b/EMS131904-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f1/7612861/25498387cb99/EMS131904-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f1/7612861/0581e97c2ced/EMS131904-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f1/7612861/283961570e7b/EMS131904-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f1/7612861/25498387cb99/EMS131904-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f1/7612861/0581e97c2ced/EMS131904-f003.jpg